Eli Lilly and Company, Moderna, Johnson & Johnson, Thermo Fisher Scientific, and UnitedHealth Group are the five Healthcare stocks to watch today, according to MarketBeat's stock screener tool. Healthcare stocks are shares of companies in the healthcare sector, such as pharmaceutical and biotechnology firms, medical-device makers, insurers, and healthcare providers. For investors, they offer exposure to businesses whose performance can be influenced by medical demand, innovation, regulation, and healthcare spending. These companies had the highest dollar trading volume of any Healthcare stocks within the last several days.
Eli Lilly and Company (LLY)
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.
Shares of LLY traded up $8.27 during trading hours on Thursday, reaching $1,445.56. The stock had a trading volume of 1,125,071 shares, compared to its average volume of 2,955,327. Eli Lilly and Company has a 12 month low of $850.51 and a 12 month high of $1,460.00. The firm has a 50-day simple moving average of $1,231.13 and a 200 day simple moving average of $1,106.42. The company has a current ratio of 1.39, a quick ratio of 1.00 and a debt-to-equity ratio of 1.17. The company has a market capitalization of $1.36 trillion, a price-to-earnings ratio of 46.92, a P/E/G ratio of 1.72 and a beta of 0.40.
Read Our Latest Research Report on LLY
Moderna (MRNA)
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines.
Shares of MRNA stock traded down $4.72 on Thursday, hitting $243.97. The stock had a trading volume of 2,925,755 shares, compared to its average volume of 12,575,120. The company has a debt-to-equity ratio of 0.52, a current ratio of 3.62 and a quick ratio of 3.47. The business has a 50 day moving average of $198.57 and a 200 day moving average of $94.60. Moderna has a 12-month low of $22.28 and a 12-month high of $280.80. The stock has a market cap of $98.72 billion, a price-to-earnings ratio of -34.46 and a beta of 1.16.
Read Our Latest Research Report on MRNA
Johnson & Johnson (JNJ)
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.
Shares of Johnson & Johnson stock traded up $4.08 during mid-day trading on Thursday, hitting $284.49. 2,252,001 shares of the stock were exchanged, compared to its average volume of 7,929,332. Johnson & Johnson has a 12 month low of $193.45 and a 12 month high of $286.08. The company has a 50-day simple moving average of $266.67 and a 200 day simple moving average of $249.23. The company has a market capitalization of $684.84 billion, a P/E ratio of 43.13, a P/E/G ratio of 2.78 and a beta of 0.22. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.74 and a current ratio of 1.02.
Read Our Latest Research Report on JNJ
Thermo Fisher Scientific (TMO)
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
Shares of TMO traded down $13.35 on Thursday, reaching $704.37. 872,058 shares of the company's stock traded hands, compared to its average volume of 2,252,298. The company has a current ratio of 1.81, a quick ratio of 1.41 and a debt-to-equity ratio of 0.71. The stock has a market cap of $260.98 billion, a PE ratio of 37.15, a PEG ratio of 2.92 and a beta of 0.84. The stock's 50 day simple moving average is $667.38 and its two-hundred day simple moving average is $556.07. Thermo Fisher Scientific has a 52-week low of $435.27 and a 52-week high of $727.56.
Read Our Latest Research Report on TMO
UnitedHealth Group (UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
UNH stock traded up $1.39 during midday trading on Thursday, hitting $404.33. The company's stock had a trading volume of 1,260,735 shares, compared to its average volume of 7,177,354. The stock has a market cap of $362.29 billion, a price-to-earnings ratio of 23.10, a PEG ratio of 1.47 and a beta of 0.51. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. The stock's 50-day moving average price is $391.12 and its 200 day moving average price is $364.76. UnitedHealth Group has a 1 year low of $255.96 and a 1 year high of $461.62.
Read Our Latest Research Report on UNH
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Eli Lilly and Company, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.
While Eli Lilly and Company currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
